Latest news
Silence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 14:00:27 GMTTenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - Investing News NetworkInvesting News Network · Mon, 10 Aug 2026 12:54:11 GMTAquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film - Investing News NetworkInvesting News Network · Mon, 10 Aug 2026 12:54:11 GMTSpyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:27 GMTHeron Therapeutics Announces Second Quarter 2026 Financial Results - GlobeNewswireGlobeNewswire · Mon, 10 Aug 2026 12:00:00 GMTElicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMTSilence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:30:00 GMTAvere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMT